공캡슐 시장 : 제품, 기능, 원재료, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Empty Capsules Market was valued at USD 3.09 billion in 2023, expected to reach USD 3.42 billion in 2024, and is projected to grow at a CAGR of 10.82%, to USD 6.36 billion by 2030.

The market for empty capsules is experiencing significant growth driven by increasing demand in pharmaceuticals, nutraceuticals, and the evolving beauty and wellness sectors. Empty capsules, defined as small soluble containers made from gelatin or plant-based materials, are essential in encapsulating substances like medications, vitamins, and dietary supplements. Their necessity stems from the need for precise dosage delivery, enhanced bioavailability, and improved patient compliance due to their ease of swallowing compared to tablets. The application of empty capsules spans from pharmaceuticals, nutraceuticals, and cosmeceuticals to food and beverage industries, with current end-use predominantly seen in pharmaceutical companies, research laboratories, and dietary supplement manufacturers. Key growth factors influencing this market include the growing aging population leading to increased chronic health issues, rising health-consciousness among consumers, and the booming demand for plant-based and vegan-friendly capsules. The digitalization of healthcare, increasing R&D activities, and the expanding acceptance of personalized medicine also provide vast potential opportunities. Innovations such as developing biodegradable and enteric-coated capsules present lucrative prospects for businesses aiming to enhance sustainability and meet consumer preferences. Nonetheless, the market faces limitations like strict regulatory standards, fluctuating raw material costs, and ethical concerns over gelatin sourced from animal by-products. Emerging challenges include competition from alternative drug delivery systems like gummy supplements and transdermal patches. To foster business growth, firms should invest in researching advanced manufacturing technologies, biodegradable sources, and customization options catering to specific drug formulations. The market is dynamic and rapidly evolving, characterized by robust competition among established players and new entrants striving for differentiation through product innovation and sustainability efforts. Firms that prioritize consumer trends and adapt to technological advancements are poised to capitalize on these evolving opportunities, thus securing a competitive edge in the empty capsules market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Empty Capsules Market

The Empty Capsules Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising aged population with susceptibility towards chronic disease
  • Increased investment in healthcare and infrastructure in developing economies
• Market Restraints
  • Fluctuating supply and price of raw materials
• Market Opportunities
  • Emerging trend of vegan capsules and tailored capsule
  • Technological advancement for enhanced bioavailability and sustainability of raw materials
• Market Challenges
  • Stringent regulatory hurdles for standardization across geographies

Porter's Five Forces: A Strategic Tool for Navigating the Empty Capsules Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Empty Capsules Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Empty Capsules Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Empty Capsules Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Empty Capsules Market

A detailed market share analysis in the Empty Capsules Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Empty Capsules Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Empty Capsules Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Empty Capsules Market

A strategic analysis of the Empty Capsules Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Empty Capsules Market, highlighting leading vendors and their innovative profiles. These include ACG, AlfaCaps LLC, Bright Pharma Caps Inc., CapsCanada, CapsulCN International CO., LTD., Capsule Connection, LLC, Carlson Laboratories, Inc., Comed Chemicals Limited, Erawat Pharma Limited, Farmacapsulas S.A., Fortcaps Healthcare Ltd. by Kumar organic products Limited, GoCaps GmbH by DENAVA GmbH, Healthcaps India Ltd., LFA Machines Oxford LTD., Lonza Group AG, Mitsubishi Chemical Group Corporation, Natural Capsules Limited, Nectar Lifesciences Ltd., SaintyCo, SavoiurCaps Pvt. Ltd., Shaoxing Kangke Capsule Co., Ltd., Silvaco A/S, Snail Pharma Industry, SUHEUNG, Sunil Healthcare Limited, The Roxlor Group, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Empty Capsules Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Gelatin Capsules and Non-Gelatin Capsules. The Gelatin Capsules is further studied across Hard Gelatin Capsules and Soft Gelatin Capsules. The Non-Gelatin Capsules is further studied across Pullulan Capsules, Starch Capsules, and Vegetable Capsules.
• Based on Functionality, market is studied across Delayed-release Capsules, Immediate-release Capsules, and Sustained-release Capsules.
• Based on Raw Material, market is studied across Bovine Source, Non-Animal Source, and Porcine Source.
• Based on Application, market is studied across Antacid & Antiflatulent Preparations, Anti-Inflammatory & Anti-Rheumatic Drugs, Antianemic Preparations, Antibiotic & Antibacterial Drugs, Cardiac Therapy Drugs, Cough & Cold Preparations, and Vitamins & Dietary Supplements.
• Based on End-User, market is studied across Cosmeceutical Industry, Nutraceutical Industry, Pharmaceutical Industry, and Research Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising aged population with susceptibility towards chronic disease
    • 5.1.1.2. Increased investment in healthcare and infrastructure in developing economies
  • 5.1.2. Restraints
    • 5.1.2.1. Fluctuating supply and price of raw materials
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging trend of vegan capsules and tailored capsule
    • 5.1.3.2. Technological advancement for enhanced bioavailability and sustainability of raw materials
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory hurdles for standardization across geographies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing significance of gelatin capsules due to versatility and cost-effectiveness
  • 5.2.2. Application: Extending applications of empty capsules in cardiac therapy drugs owing to efficacy and patient compliance
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Empty Capsules Market, by Product

• 6.1. Introduction
• 6.2. Gelatin Capsules
  • 6.2.1. Hard Gelatin Capsules
  • 6.2.2. Soft Gelatin Capsules
• 6.3. Non-Gelatin Capsules
  • 6.3.1. Pullulan Capsules
  • 6.3.2. Starch Capsules
  • 6.3.3. Vegetable Capsules

7. Empty Capsules Market, by Functionality

• 7.1. Introduction
• 7.2. Delayed-release Capsules
• 7.3. Immediate-release Capsules
• 7.4. Sustained-release Capsules

8. Empty Capsules Market, by Raw Material

• 8.1. Introduction
• 8.2. Bovine Source
• 8.3. Non-Animal Source
• 8.4. Porcine Source

9. Empty Capsules Market, by Application

• 9.1. Introduction
• 9.2. Antacid & Antiflatulent Preparations
• 9.3. Anti-Inflammatory & Anti-Rheumatic Drugs
• 9.4. Antianemic Preparations
• 9.5. Antibiotic & Antibacterial Drugs
• 9.6. Cardiac Therapy Drugs
• 9.7. Cough & Cold Preparations
• 9.8. Vitamins & Dietary Supplements

10. Empty Capsules Market, by End-User

• 10.1. Introduction
• 10.2. Cosmeceutical Industry
• 10.3. Nutraceutical Industry
• 10.4. Pharmaceutical Industry
• 10.5. Research Laboratories

11. Americas Empty Capsules Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Empty Capsules Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Empty Capsules Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Roquette Introduced A Versatile Plant-Based Solution LYCAGEL Flex for Customizable Softgel Capsules
  • 14.3.2. Kumar Organic Products Ltd. Expanded Portfolio with Acquisition of Fortcaps Healthcare Ltd.
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ACG
• 2. AlfaCaps LLC
• 3. Bright Pharma Caps Inc.
• 4. CapsCanada
• 5. CapsulCN International CO., LTD.
• 6. Capsule Connection, LLC
• 7. Carlson Laboratories, Inc.
• 8. Comed Chemicals Limited
• 9. Erawat Pharma Limited
• 10. Farmacapsulas S.A.
• 11. Fortcaps Healthcare Ltd. by Kumar organic products Limited
• 12. GoCaps GmbH by DENAVA GmbH
• 13. Healthcaps India Ltd.
• 14. LFA Machines Oxford LTD.
• 15. Lonza Group AG
• 16. Mitsubishi Chemical Group Corporation
• 17. Natural Capsules Limited
• 18. Nectar Lifesciences Ltd.
• 19. SaintyCo
• 20. SavoiurCaps Pvt. Ltd.
• 21. Shaoxing Kangke Capsule Co., Ltd.
• 22. Silvaco A/S
• 23. Snail Pharma Industry
• 24. SUHEUNG
• 25. Sunil Healthcare Limited
• 26. The Roxlor Group
• 27. Thermo Fisher Scientific Inc.